ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Eight Win ASCO Young Investigator Awards

August 22, 1986

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

The Cancer Letter Stands By Story

October 30, 1998

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

November 16, 1979

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011